_scan_pd.jpg)
the Medical Equipment & Supplies company had astonishing Dec 31 2022 report, where profit per share jumped by 42.22 % to $0.64 per share, followed by Revenue rise of 17.528 % to $
305.30 millions, compared with the prior year period.
Eps remained unscathed from the prior reporting season from $0.64 per share, Revenues grew by 2.627 % from $297.49 millions.
Net income of $32.944 millions in the October to December 31 2022 period increased by 41.8 % from net earnings of $23.232 millions reported in the October to December 31 2022 period a year ago. Haemonetics Corporation also emphasized it's improving profit margins, where net margin rose to 10.79% in October to December 31 2022 period, and operating margin edged up to 14.18%.
Operating earnings, on the other hand, improved just 21.4% to $43.279 millions.
Haemonetics Corporation is expected to report next financial recent numbers on May 24, 2023.